Innate Pharma and Sanofi Restructure 2016 Research Agreement on CD123 ANKET Drug
France-based Innate Pharma SA has announced a significant adjustment to its 2016 research and licensing...
Innate Pharma
Sanofi Expands Oncology Portfolio with NK Cell Engager In-License from Innate Pharma
Sanofi (NASDAQ: SNY) has in-licensed a natural killer (NK) cell engager candidate for solid tumors...